Europe — EMA
Moxonidine Pch
GNH USA supplies Moxonidine Pch (Moxonidine), an imidazoline receptor agonist for hypertension, suitable for adult patients.
Request sourcing
What is Moxonidine?
Moxonidine, the active ingredient in Moxonidine Pch, is an Imidazoline receptor agonist presented as an oral dosage form for oral use. It is used to treat hypertension in adult patients by reducing sympathetic nervous system activity. GNH USA supplies Moxonidine Pch as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Moxonidine used for?
Moxonidine is an antihypertensive agent that lowers elevated blood pressure by acting on central imidazoline I1 receptors. - Hypertension: reduces systolic and diastolic blood pressure in patients with essential hypertension.
What are the side effects of Moxonidine?
Moxonidine may cause a range of adverse reactions, most of which are mild and reversible.
Common Side Effects: - Dry mouth: sensation of oral dryness. - Fatigue: feeling of reduced energy or tiredness. - Dizziness: light‑headedness, especially on standing. - Headache: mild to moderate cranial pain.
Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Bradycardia: abnormally slow heart rate. - Allergic reactions: rash, itching, or swelling of the face and throat.
What precautions apply to Moxonidine?
Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications. - Blood pressure monitoring: check regularly to avoid excessive hypotension. - Renal impairment: adjust dose in patients with reduced kidney function. - Hepatic disease: use cautiously in liver dysfunction. - Elderly patients: start at the lowest effective dose and titrate slowly. - Discontinuation: avoid abrupt cessation; taper if long‑term therapy is stopped. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.
What does Moxonidine interact with?
Moxonidine can interact with several drug classes, influencing its antihypertensive effect or safety profile.
Major Interactions (Avoid): - Clonidine: additive central sympatholytic effect may cause profound hypotension. - Other antihypertensives (ACE inhibitors, ARBs, calcium channel blockers): risk of excessive blood pressure lowering. - Beta‑blockers: combined effect may lead to bradycardia and hypotension.
Moderate Interactions (Monitor Closely): - NSAIDs: may blunt the blood‑pressure‑lowering response. - Diuretics: electrolyte disturbances can potentiate hypotensive episodes. - Alcohol: enhances dizziness and orthostatic hypotension.



